Open access
Aug 2026
Association of baseline serum albumin with treatment-related toxicities in patients receiving tyrosine kinase inhibitors: a real-world cohort study
Tyrosine kinase inhibitors (TKIs) are widely used across multiple malignancies, but treatment-related toxicities remain a major cause of healthcare utilization and treatment modification. Serum albumin is a routinely available biomarker that reflects nutritional status, systemic inflammation, and physiologic vuln...
Ahmed S. Alanazi, Mohammed A. Alnuhait, Norah M. Almutairi et al.
· BMC Cancer · 0 citations